John Viggiano
519 posts


Zero, that's ZERO crude oil tankers have passed the Strait of Hormuz in the past 24 hours. Be afraid. Be very afraid.















Our community were provided a clear 'heads up' on a primer set up on Hecla Stock #HL just prior to an earnings report in Aug/Sep. We suggested this would be the beginning of a run through $85 [localised high target, before pressing even higher] the price then was between $5-$6 dollars at the time. The RRR value would be 565 RRR. We later shared this on YT, and again later in a chat with @dondurret. We aggressively bought HL Long dated Calls with OTM strikes at $20, $25, $37 with Jan 2028 expiry's. Hecla Gap'd wildly on its results on our primer HVF technical set up and largely has NOT looked back since is 5X up and melting up. Ask yourself how many potential 565 RRR trades you are in? #HVFmethod The first chart shared is intentionally NOT log scaled as we normally would, to illustrate the proportion of this call. The second chart is the primer break post results. @theresetSniper @thecryptosniper Then Book your call to discuss joining the community below: shorturl.at/egN8v



The Best form of Omega-3 Matters (🔗 in 8/8) (1/8) Alzheimer’s disease is personal for me. In my early 20s, I discovered I carry the ApoE4/4 genotype—placing me at the highest genetic risk. I was terrified. But over time, that fear shifted to a realization: 👉A genetic predisposition is a vulnerability, not a destiny. 👉 Our choices shape our health trajectory more than our genes ever could. Today, I want to share a piece of that puzzle: The Omega-3 Paradox. 👉The Signal: Data clearly shows eating fatty fish lowers Alzheimer’s rates and boosts cognitive longevity. 👉The Failure: Yet, large clinical trials using Omega-3 supplements often fail to protect the brain. 👉The Question: Why? One answer lies in a specific delivery mechanism most people—and many researchers—overlook. Here is the science of getting Omega-3s into the brain. 🧵👇















